MedPath
FDA Approval

Sufentanil Citrate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Akorn
DUNS: 117693100
Effective Date
September 14, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Sufentanil(50 ug in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Akorn

Akorn

117696832

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sufentanil Citrate

Product Details

NDC Product Code
17478-050
Application Number
NDA019050
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS, EPIDURAL
Effective Date
March 31, 2014
Code: S9ZFX8403RClass: ACTIMQuantity: 50 ug in 1 mL
WaterInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath